Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy
Abstract Background Immunotherapy targeting PD-1/PD-L1 fails to induce clinical responses in most patients with solid cancers. N-803, formerly ALT-803, is an IL-15 superagonist mutant and dimeric IL-15RαSushi-Fc fusion protein complex that enhances CD8+ T and NK cell expansion and function and exhib...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2019-03-01
|
| Serier: | Journal for ImmunoTherapy of Cancer |
| Fag: | |
| Online adgang: | http://link.springer.com/article/10.1186/s40425-019-0551-y |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
